• Issue

    Journal of Viral Hepatitis: Volume 26, Issue 12

    1359-1501
    December 2019
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 1359-1361
  • First Published: 11 November 2019

COMMISSIONED REVIEW

Use of HCV-infected organs in solid organ transplantation: An ethical challenge but plausible option

Gayatri Nangia,  Kelly Borges,  K. Rajender Reddy, 
  • Pages: 1362-1371
  • First Published: 20 May 2019

ORIGINAL ARTICLES

Surveillance factors change outcomes in patients with hepatocellular carcinoma due to chronic hepatitis C virus infection in New Zealand

Cameron Schauer,  Marius van Rijnsoever,  Edward Gane, 
  • Pages: 1372-1376
  • First Published: 19 July 2019

Risk behaviours of homeless people who inject drugs during an outbreak of hepatitis C, Northern Ireland, 2016-2017

Anna Maisa,  Susan Semple,  Alison Griffiths,  Siew Lin Ngui,  Neville Q. Verlander,  Conall McCaughey,  Lorraine Doherty,  Lucy Jessop, on behalf of the Outbreak Control Team , 
  • Pages: 1377-1387
  • First Published: 22 July 2019

Modelling the potential prevention benefits of a treat-all hepatitis C treatment strategy at global, regional and country levels: A modelling study

Adam Trickey,  Hannah Fraser,  Aaron G. Lim,  Josephine G. Walker,  Amy Peacock,  Samantha Colledge,  Janni Leung,  Jason Grebely,  Sarah Larney,  Natasha K. Martin,  Louisa Degenhardt,  Matthew Hickman,  Margaret T. May,  Peter Vickerman, 
  • Pages: 1388-1403
  • First Published: 07 August 2019

ORIGINAL PAPER

Evolution of renal function under direct-acting antivirals treatment for chronic hepatitis C: A real-world experience

Ming-Chao Tsai,  Chun-Yen Lin,  Chao-Hung Hung,  Sheng-Nan Lu,  Shui-Yi Tung,  Rong-Nan Chien,  Chih-Lang Lin,  Jing-Houng Wang,  Chen Chien-Hung,  Kuo-Chin Chang,  Tsung-Hui Hu,  I-Shyan Sheen, 
  • Pages: 1404-1412
  • First Published: 21 August 2019

ORIGINAL ARTICLES

Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada

Brendan Jacka,  Élise Roy,  Stine Høj,  Nanor Minoyan,  Andreea Adelina Artenie,  Geng Zang,  Didier Jutras-Aswad,  Julie Bruneau, 
  • Pages: 1413-1422
  • First Published: 21 August 2019

Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study

Beth Catlett,  Francois M. J. Lamoury,  Sahar Bajis,  Behzad Hajarizadeh,  Danica Martinez,  Yasmin Mowat,  Philip H. Cunningham,  Brendan P. Jacka,  Gavin A Cloherty,  Philippa Marks,  Gregory J. Dore,  Jason Grebely,  Tanya L. Applegate, 
  • Pages: 1423-1430
  • First Published: 26 August 2019
Open Access

Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: A systematic review

Lauren M. K. Mason,  Irene K. Veldhuijzen,  Erika Duffell,  Ayla van Ahee,  Eveline M. Bunge,  Andrew J. Amato-Gauci,  Lara Tavoschi, 
  • Pages: 1431-1453
  • First Published: 22 July 2019

Kinetics of hepatitis B surface antigen quasispecies during REP 2139-Ca therapy in HBeAg-positive chronic HBV infection

Zainab Usman,  Hrvoje Mijočević,  Hadi Karimzadeh,  Martin Däumer,  Mamun Al-Mathab,  Michel Bazinet,  Dmitrij Frishman,  Andrew Vaillant,  Michael Roggendorf, 
  • Pages: 1454-1464
  • First Published: 19 July 2019

The risk of hepatocellular carcinoma among chronic hepatitis B virus-infected patients outside current treatment criteria

Dong Hyun Sinn,  Sung Eun Kim,  Beom Kyung Kim,  Ji Hoon Kim,  Moon Seok Choi, 
  • Pages: 1465-1472
  • First Published: 22 July 2019

Hepatitis B core-related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinoma

Wai-Pan To,  Lung-Yi Mak,  Danny Ka-Ho Wong,  James Fung,  Fen Liu,  Wai-Kay Seto,  Ching-Lung Lai,  Man-Fung Yuen, 
  • Pages: 1473-1480
  • First Published: 16 August 2019

Baseline and kinetics of serum hepatitis B virus RNA predict response to pegylated interferon-based therapy in patients with hepatitis B e antigen-negative chronic hepatitis B

Umaporn Limothai,  Natthaya Chuaypen,  Kittiyod Poovorawan,  Watcharasak Chotiyaputta,  Tawesak Tanwandee,  Yong Poovorawan,  Pisit Tangkijvanich, 
  • Pages: 1481-1488
  • First Published: 25 August 2019

SHORT COMMUNICATIONS

The dynamic effect of direct-acting antiviral treatments on the risk of hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis C

Clovis Lusivika-Nzinga,  Hélène Fontaine,  Céline Dorival,  Mélanie Simony,  Stanislas Pol,  Fabrice Carrat, for the ANRS/AFEF Hepather study group , 
  • Pages: 1489-1492
  • First Published: 06 August 2019

Laboratory reform counteracts the WHO hepatitis C elimination strategy in Germany

Jan Kramer,  Ingmar Wolffram,  Uli Früh,  Olaf Bätz,  Thomas Berg,  Johannes Wiegand, 
  • Pages: 1493-1495
  • First Published: 06 August 2019

Cascade of care for migrants tested Hepatitis C antibodies positive in France through a systematic screening programme: The PRECAVIR study

Isabelle Rosa-Hezode,  Michel Chousterman,  Laurent Costes,  Charlotte Labourdette,  Bernard Elghozi,  Evguenia Krastinova,  Françoise Roudot-Thoraval, 
  • Pages: 1496-1499
  • First Published: 21 August 2019

LETTERS TO THE EDITOR

It is too early to evaluate mother-to-child transmission of hepatitis B within 24 hours after delivery

Xueru Yin, 
  • Page: 1500
  • First Published: 14 August 2019

Last crusade against HCV: Direct-acting antiviral treatment for marginalized populations

Hideki Fujii,  Masaru Enomoto,  Yoshiki Murakami,  Atsushi Hagihara,  Norifumi Kawada,  Shinobu Saito, 
  • Page: 1501
  • First Published: 14 August 2019